Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Novartis Ireland Limited .
Filed returns
9
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | Novartis Ireland Limited | Foreign Affairs | Policy Agenda for the EU Presidency (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2025 | Novartis Ireland Limited | Health | Forwarding letter to Dept of Health about access to innovative treatment for Irish patients (Public policy or programme) | 6 | On lobbying.ie |
| Sep–Dec 2025 | Novartis Ireland Limited | Health | Advocate for Life Science Strategy (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | Health | Letter to Tanaiste about access to innovative treatment for Irish patients (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | EU Affairs | Attending a meeting organised by Hanover with the Minister for EU Affairs (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | Foreign Affairs | EU Presidency (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | Health | Rare diseases conference, as an official event of the Irish EU Presidency (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2025 | Novartis Ireland Limited | Health | IPHA Industry meeting - engagement on trade and tariff issues (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Novartis Ireland Limited | Health | Competitivness, government needs to be perceived as pro-innovation (Legislation) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 6 | 66.7% | |
| Foreign Affairs | 2 | 22.2% | |
| EU Affairs | 1 | 11.1% |